These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11500483)

  • 1. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism.
    Erbay E; Chen J
    J Biol Chem; 2001 Sep; 276(39):36079-82. PubMed ID: 11500483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin.
    Shu L; Zhang X; Houghton PJ
    J Biol Chem; 2002 May; 277(19):16726-32. PubMed ID: 11875068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
    Fingar DC; Salama S; Tsou C; Harlow E; Blenis J
    Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.
    Dilling MB; Germain GS; Dudkin L; Jayaraman AL; Zhang X; Harwood FC; Houghton PJ
    J Biol Chem; 2002 Apr; 277(16):13907-17. PubMed ID: 11847216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).
    Ge Y; Yoon MS; Chen J
    J Biol Chem; 2011 Oct; 286(41):35675-35682. PubMed ID: 21852229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.
    Shu L; Houghton PJ
    Mol Cell Biol; 2009 Sep; 29(17):4691-700. PubMed ID: 19564418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
    Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
    Han B; Tong J; Zhu MJ; Ma C; Du M
    Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
    El-Chaâr D; Gagnon A; Sorisky A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bepsilon mRNA in a mammalian target of rapamycin-dependent manner.
    Kubica N; Bolster DR; Farrell PA; Kimball SR; Jefferson LS
    J Biol Chem; 2005 Mar; 280(9):7570-80. PubMed ID: 15591312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
    Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
    J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin.
    McMahon LP; Choi KM; Lin TA; Abraham RT; Lawrence JC
    Mol Cell Biol; 2002 Nov; 22(21):7428-38. PubMed ID: 12370290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of resistance to rapamycin in human cancer cells.
    Hosoi H; Dilling MB; Liu LN; Danks MK; Shikata T; Sekulic A; Abraham RT; Lawrence JC; Houghton PJ
    Mol Pharmacol; 1998 Nov; 54(5):815-24. PubMed ID: 9804616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
    Mita MM; Mita A; Rowinsky EK
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S169-77. PubMed ID: 14508096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis.
    Cuenda A; Cohen P
    J Biol Chem; 1999 Feb; 274(7):4341-6. PubMed ID: 9933636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells.
    Canicio J; Gallardo E; Illa I; Testar X; Palacín M; Zorzano A; Kaliman P
    Endocrinology; 1998 Dec; 139(12):5042-9. PubMed ID: 9832443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
    Wu AL; Kim JH; Zhang C; Unterman TG; Chen J
    Endocrinology; 2008 Mar; 149(3):1407-14. PubMed ID: 18079193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.